pharmaceuticals

Denmark’s Novo Nordisk says US launch ‘encouraging’
PHARMACEUTICALS

Denmark’s Novo Nordisk says US launch ‘encouraging’

Wealthy Danish foundations keep pharma groups healthy
PHARMACEUTICALS

Wealthy Danish foundations keep pharma groups healthy

Denmark's biopharmaceutical sector, led by insulin giant Novo Nordisk, is experiencing a golden age as researchers reap the rewards of a unique ownership structure: deep-pocketed, non-profit foundations.